181633-60-3

Basic information

• Product Name: Ethyl2-forMyloxazole-4-carboxylate
• Synonyms: Ethyl2-forMyloxazole-4-carboxylate;2-Formyl-oxazole-4-carboxylic acid ethyl ester
• CAS NO: 181633-60-3
• Molecular Formula: C₇H₇NO₄
• Molecular Weight: 169.13478
• Mol File: 181633-60-3.mol
• Article Data: 11

Chemical Properties

• Boiling Point: 282.9±32.0 °C(Predicted)
• Appearance: /
• Density: 1.285±0.06 g/cm3(Predicted)
• PKA: -4.49±0.10(Predicted)
• CAS DataBase Reference: Ethyl2-forMyloxazole-4-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: Ethyl2-forMyloxazole-4-carboxylate(181633-60-3)
• EPA Substance Registry System: Ethyl2-forMyloxazole-4-carboxylate(181633-60-3)

Safety Data

• Hazardous Substances Data: 181633-60-3(Hazardous Substances Data)

Usage

General Description

Ethyl 2-formyloxazole-4-carboxylate is a chemical compound with the formula C8H9NO4. It is a colorless to pale yellow liquid and is commonly used as an intermediate in the production of pharmaceuticals and agrochemicals. Ethyl2-forMyloxazole-4-carboxylate is also used in the synthesis of other organic compounds and has been studied for its potential biological and pharmacological activities. It is important to handle this chemical with care, as it may be harmful if ingested, inhaled, or in contact with skin. Additionally, it should be stored in a cool, dry place away from heat and direct sunlight.

Upstream product

• 107367-69-1 C₁₄H₁₃NO₃ 
• 70-23-5 ethyl Bromopyruvate 
• 132629-37-9 ethyl 2-[(E)-2-phenylethenyl]oxazole-4-carboxylate 
• 181633-66-9 2-(1,2-Dihydroxy-2-phenyl-ethyl)-oxazole-4-carboxylic acid ethyl ester 

Downstream Products

• 617705-26-7 2-ethynyloxazole-4-carboxylic acid ethyl ester 
• 603999-34-4 C₂₇H₂₇F₃N₄O₆ 
• 224578-16-9 2-(4-Methoxy-benzyloxymethyl)-oxazole-4-carbaldehyde 
• 181633-69-2 2'-Methoxymethoxymethyl-[2,4']bioxazolyl-4-carboxylic acid [(1R,2R)-1-benzyloxymethyl-3-(tert-butyl-diphenyl-silanyloxy)-2-methyl-propyl]-amide 
• 181633-64-7 2'-Methoxymethoxymethyl-[2,4']bioxazolyl-4-carboxylic acid [(1R,2R)-3-(tert-butyl-diphenyl-silanyloxy)-1-hydroxymethyl-2-methyl-propyl]-amide 
• 1026522-61-1 2'-Methoxymethoxymethyl-[2,4']bioxazolyl-4-carboxylic acid [(1R,2R)-3-(tert-butyl-diphenyl-silanyloxy)-1-formyl-2-methyl-propyl]-amide 
• 617705-31-4 2-{(E)-4-[(1S,2S)-2-(4-Methoxy-benzyloxymethyl)-cyclopropyl]-but-3-en-1-ynyl}-oxazole-4-carboxylic acid ethyl ester 

Relevant articles and documents

MODULATORS OF THE INTEGRATED STRESS PATHWAY

Provided herein are compounds, compositions, and methods useful for modulating the integrated stress response (ISR) and for treating related diseases; disorders and conditions.

TRICYCLIC PIPERIDINE COMPOUNDS

The present invention relates to compounds of the formula (I), wherein R, R1a, R1b, R2, R3, and X are as described in the description, to their preparation, to pharmaceutically acceptable salts thereof, and to their use as pharmaceuticals, to pharmaceutical compositions containing one or more compounds of formula (I), to methods for the preparation of such compounds of formula (I), and especially to their use as TPH modulators.

2-AMINO-6-METHYL-4,4a,5,6-TETRAHYDROPYRANO[3,4-d][1,3]THIAZIN-8a(8H)-YL-1,3-THIAZOL-4-YL AMIDES

The present invention is directed to compounds, tautomers and pharmaceutically acceptable salts of the compounds which are disclosed, wherein the compounds have the structure of Formula (I), and the variable R1 is as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.